Confirmed six-month disability progression rates over 4 years were similar in patients given the oral statin or a placebo in ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...

Scientists compared high-intensity statins rosuvastatin and atorvastatin, and found both are broadly safe and effective at ...

A common drug taken by millions of people in the UK has been linked to an increased risk of diabetes. Statins are taken for a ...

Navigating the complex world of prescription drug pricing can feel overwhelming, particularly with the ever-increasing costs ...

Simvastatin could be an effective therapy for portal hypertension, according to a study by Abraldes and colleagues, which shows that the drug decreases portal hypertension and improves liver ...

Larger statin doses raise those risks. So does taking a statin, particularly simvastatin, in combination with certain other drugs, including: The cholesterol-lowering drug ezetimibe (Zetia ...

Treatment combining the cholesterol drug simvastatin with the B vitamin niacin lowers the risk of heart attack and other artery-disease complications by up to 90% in some patients. The study of ...

Pitavastatin is a novel statin that induces plaque regression and is non-inferior to atorvastatin and, on some measures, superior to simvastatin and to pravastatin in the elderly. Pitavastatin ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...